Hershey Trust CO Crinetics Pharmaceuticals, Inc. Transaction History

Hershey Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$17.15 - $28.31 $128,985 - $212,919	-7,521 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$19.35 - $28.41 $145,531 - $213,671	7,521 New	7,521 $214,000
Q3 2021 Nov 12, 2021	SELL	$16.88 - $25.23 $333,852 - $498,998	-19,778 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$13.04 - $23.23 $220,154 - $392,192	16,883 Added 583.18%	19,778 $347,000
Q1 2020 Apr 20, 2020	SELL	$11.52 - $26.46 $44,444 - $102,082	-3,858 Reduced 57.13%	2,895 $43,000
Q2 2019 Aug 08, 2019	SELL	$21.48 - $27.71 $90,087 - $116,215	-4,194 Reduced 38.31%	6,753 $169,000
Q1 2019 Apr 22, 2019	BUY	$21.07 - $29.31 $230,653 - $320,856	10,947 New	10,947 $249,000

242

79.6M

23.3K

44.3K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.98B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

Stay updated on Hershey Trust CO with notifications on news.